1. Home
  2. Stocks
  3. Fortis Share Price

Fortis Healthcare Share Price

Healthcare Large Cap

₹614.05 -21 (-3.31%)

05 Nov, 2024 20:51

SIP TrendupStart SIP in FORTIS

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹605
  • High
  • ₹634
  • 52 Week Low
  • ₹331
  • 52 Week High
  • ₹644
  • Open Price₹633
  • Previous Close₹635
  • Volume1,799,778

Investment Returns

  • Over 1 Month + 5.62%
  • Over 3 Month + 21.43%
  • Over 6 Month + 35.87%
  • Over 1 Year + 83.79%
SIP Lightning

Smart Investing Starts Here Start SIP with Fortis Healthcare for Steady Growth!

Fortis Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 71
  • PEG Ratio
  • 5.5
  • Market Cap Cr
  • 46,358
  • P/B Ratio
  • 5.4
  • Average True Range
  • 20.06
  • EPS
  • 1.6
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 7.68
  • RSI
  • 54.18
  • MFI
  • 39.08

Fortis Healthcare Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations333.40307.48290.75294.12289.07
Total Income From Operations333.40307.48290.75294.12289.07
P/L Before Interest, Excpt. Items & Tax67.3475.9555.1662.7640.96
P/L Before Exceptional Items & Tax50.5057.5135.7941.9517.66
P/L After Tax from Ordinary Activities26.8368.3322.9495.3012.88
Net Profit/Loss For the Period26.8368.3322.9495.3012.88
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,170.181,039.03
Revenue From Operations [Net]1,170.181,039.03
Total Operating Revenues1,181.421,052.93
Total Revenue1,324.431,202.50
Total Expenses1,171.511,141.90
Profit/Loss Before Tax246.56108.88
Profit/Loss For The Period199.4596.24
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity218.45198.38
Net Cash Used In Investing Activity44.46204.65
Net Cash Used in Finance Activity-245.35-395.43
Net Inc/Dec In Cash And Equivalent17.567.57
Cash And Equivalent End Of Year5.37-12.18
IndicatorMar 24Mar 23
Total Share Capital754.96754.96
Total Non-Current Liabilities539.62648.16
Total Current Liabilities760.13756.98
Total Capital And Liabilities10,386.9110,368.67
Total Non-Current Assets9,745.429,678.55
Total Current Assets641.50690.12
Total Assets10,386.9110,368.67
Indicator20242023
EBIT Margin (%)19.8715.84
Return On Capital Employed (%)2.431.73
Return On Equity (%)2.191.07
Long Term Debt To Equity (%)2.793.14
Book Value/Share (INR)120.37118.73
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations1,858.901,785.881,679.681,769.951,657.41
Total Income From Operations1,858.901,785.881,679.681,769.951,657.41
P/L Before Interest, Excpt. Items & Tax264.53298.61203.87259.55201.36
P/L Before Exceptional Items & Tax229.26263.92170.91227.74169.87
P/L After Tax from Ordinary Activities173.39198.82129.70182.62124.57
Net Profit/Loss For the Period173.39198.82129.70182.62124.57
IndicatorMar 24Mar 23
Revenue From Operations [Gross]6,835.096,213.15
Revenue From Operations [Net]6,835.096,213.15
Total Operating Revenues6,892.926,297.63
Total Revenue6,931.176,359.35
Total Expenses6,098.735,641.12
Profit/Loss Before Tax848.46791.84
Profit/Loss For The Period635.71611.15
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity1,100.10822.25
Net Cash Used In Investing Activity-886.37-373.70
Net Cash Used in Finance Activity-86.46-471.22
Net Inc/Dec In Cash And Equivalent124.52-21.46
Cash And Equivalent End Of Year169.6645.15
IndicatorMar 24Mar 23
Total Share Capital754.96754.96
Total Non-Current Liabilities1,562.472,907.34
Total Current Liabilities3,170.171,425.88
Total Capital And Liabilities13,288.7812,433.60
Total Non-Current Assets11,868.1911,027.25
Total Current Assets1,420.591,406.35
Total Assets13,288.7812,433.60
Indicator20242023
EBIT Margin (%)13.9713.45
Return On Capital Employed (%)9.527.69
Return On Equity (%)7.818.12
Long Term Debt To Equity (%)9.667.90
Book Value/Share (INR)113.33107.30

Fortis Healthcare Technicals

EMA & SMA

Current Price
₹614.05
-21 (-3.31%)
pointer
  • stock-down_img
  • Bullish Moving Average 13
  • stock-up_img
  • Bearish Moving Average 3
  • 20 Day
  • ₹608.02
  • 50 Day
  • ₹586.15
  • 100 Day
  • ₹550.96
  • 200 Day
  • ₹499.75

Resistance and Support

617.48 Pivot Speed
  • R3 658.67
  • R2 646.08
  • R1 630.07
  • S1 601.47
  • S2 588.88
  • S3 572.87

Is Fortis Healthcare Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Fortis Healthcare Limited, an IHH Healthcare Berhad Company, is a leading healthcare provider in India with 28 facilities, 4,500+ operational beds, and 400+ diagnostics centers. It offers comprehensive healthcare services across India, UAE, Nepal, and Sri Lanka. Fortis Healthcare (Nse) has an operating revenue of Rs. 7,094.41 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 12% is healthy, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 28% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Fortis Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-08 Quarterly Results
2024-10-09 Others Inter alia, to consider and approve the issue of Non-Convertible Debentures (NCD). per share(10%)Final Dividend
2024-08-30 To consider Fund Raising
2024-08-06 Quarterly Results
2024-05-23 Audited Results & Final Dividend
Date Purpose Remarks
2024-07-24 FINAL Rs.1.00 per share(10%)Final Dividend
2023-07-20 FINAL Rs.1.00 per share(10%)Final Dividend

Fortis Healthcare F&O

Fortis Healthcare Shareholding Pattern

31.17%
27.23%
2.2%
25.26%
1.19%
10.35%
2.6%
  • NSE Symbol
  • FORTIS
  • BSE Symbol
  • 532843
  • Managing Director & CEO
  • Dr. Ashutosh Raghuvanshi
  • ISIN
  • INE061F01013

Fortis Healthcare FAQs

Fortis Healthcare share price is ₹614 As on 05 November, 2024 | 20:37

The Market Cap of Fortis Healthcare is ₹46358.2 Cr As on 05 November, 2024 | 20:37

The P/E ratio of Fortis Healthcare is 71 As on 05 November, 2024 | 20:37

The PB ratio of Fortis Healthcare is 5.4 As on 05 November, 2024 | 20:37

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.